Episodios

  • Managing AMD: Integrating Newer Therapies

    Managing AMD: Integrating Newer Therapies
    May 8 2024
    Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approaches. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    25 m
  • Diabetic Macular Edema

    Diabetic Macular Edema
    May 8 2024
    In this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation therapies into the armamentarium. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    18 m
  • DME Treatment Strategies With Longer Duration Therapies

    DME Treatment Strategies With Longer Duration Therapies
    May 8 2024
    Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF injections who was switched to aflibercept 8 mg. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    19 m
  • Optimizing Management Strategies in Challenging Cases

    Optimizing Management Strategies in Challenging Cases
    May 8 2024
    In this episode, Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, one involving a 15-year-old who presents with neovascularization and an elderly patient with an extensive history of treatment who was switched to a second-generation therapy. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    20 m
  • Next-Generation Anti-VEGFs: Finding Durable Solutions to Retinal Diseases

    Next-Generation Anti-VEGFs: Finding Durable Solutions to Retinal Diseases
    May 8 2024
    David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the newer agents through challenging real-world case studies. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    26 m
  • Considerations for More Durable Agents in Treatment of Neovascular Age-Related Macular Degeneration: Data Review and Case Studies

    Considerations for More Durable Agents in Treatment of Neovascular Age-Related Macular Degeneration: Data Review and Case Studies
    May 8 2024
    David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    26 m
  • GA Perspectives: Dry AMD Follow-Up and a Patient With Advanced Glaucoma and History of Retinal Detachment

    GA Perspectives: Dry AMD Follow-Up and a Patient With Advanced Glaucoma and History of Retinal Detachment
    Oct 4 2023
    Roger A. Goldberg, MD, MBA, presents two cases: presents two cases: an 111-year-old patient who presents for a dry age-related macular degeneration follow-up and a patient with geographic atrophy who also has advanced glaucoma and a history of retinal detachment. This activity is supported by an independent medical education grant from Apellis Pharmaceuticals. Click here to view Dr. Goldberg's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    13 m
  • GA Perspectives: Foveal-Involving GA and Exudative AMD

    GA Perspectives: Foveal-Involving GA and Exudative AMD
    Oct 4 2023
    Roger A. Goldberg, MD, MBA, presents two cases: a patient with foveal-involving geographic atrophy and a patient with geographic atrophy who developed exudative age-related macular degeneration. This activity is supported by an independent medical education grant from Apellis Pharmaceuticals. Click here to view Dr. Goldberg's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Más Menos
    15 m